Lung Cancer Screening: Update 2012

| | Health Imaging | Oncology Imaging

Monday, Nov. 26, 8:30-10:00 a.m.| E405A

This session presents the issues involved in planning and establishing a lung cancer screening program. It features a discussion of the risks and benefits of screening and a discussion of the National Lung Screening Trial, and also will cover the resources needed to undertake a screening program.

Speaker Information:

  • Caroline Chiles, MD, Wake Forest Baptist Medical Center, Winston-Salem, N.C.
  • Denise Aberle, MD, University of California, Los Angeles
  • Reginald Munden, MD, DMD, MD Anderson Cancer Center, Houston
  • Thomas Hartman, MD, Mayo Clinic, Rochester, Minn.

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.